Name: Quanex Building Products Corp (NX) Fundamental & Financial Data
Creator: Stocktwits

SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending due to a blowout earnings report featuring exceptional growth in U.S. commercial and government revenue that significantly exceeded market expectations. The community is actively debating the company's long-term growth trajectory and valuation, with bullish investors celebrating the accelerating demand for its AI platform while skeptics continue to question the sustainability of the stock's current price levels.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is seeing heightened volatility and intense social media debate following an announcement regarding a convertible debt-to-equity swap, which investors are interpreting as a dilutive event. The community is sharply divided, with some critics labeling the move as detrimental to long-term shareholders, while others argue it strengthens the company's balance sheet for future strategic acquisitions.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending as investor focus shifts to its upcoming earnings, with the community actively debating whether recent advertising improvements and subscription growth can finally drive a sustained turnaround for the stock. Bullish sentiment highlights potential in AI-integrated hardware and cost-discipline, while skeptics remain focused on founder-controlled governance, ongoing user base challenges, and the historical volatility surrounding earnings reports.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is trending as investors eagerly anticipate upcoming earnings, with the community closely tracking the potential for a guidance raise driven by the dominant performance of Mounjaro and Zepbound. The stock continues to benefit from its leading role in the GLP-1 sector, as market participants debate the stock's valuation, recent institutional interest, and the impact of the newly launched Foundayo on the broader obesity treatment landscape.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is experiencing intense volatility as traders weigh reports of renewed military escalations in the Middle East against persistent, market-moving claims from the White House regarding imminent peace deals. Investors are closely monitoring the Strait of Hormuz for potential supply disruptions, while the broader community remains deeply divided over the reliability of diplomatic announcements versus the reality of depleted strategic reserves.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng, Brian Wilson, Nilay Patel and Damon Uyeda in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblaze is surging after announcing a 335 million dollar multi-year agreement with CoreWeave to support AI infrastructure and data storage needs. The community is actively debating the stock's valuation, institutional accumulation, and the potential for a share offering amidst this high-momentum breakout.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense & National Security, Space Solutions, and Starlab Space Stations. The Defense & National Security segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Space Solutions segment consists of space infrastructure, advanced space technology, science systems and mission services. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyager Technologies (VOYG) is rallying significantly following a major earnings beat that featured record bookings, an increased full-year revenue outlook, and a substantial boost in backlog. The community is heavily focused on the company's successful scale-up of its space infrastructure and defense contracts, viewing the stock as a compelling long-term play despite ongoing discussions regarding profitability and scaling margins.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending as market participants focus on strong revenue growth from its core multiple sclerosis drug, Briumvi, and anticipation surrounding its upcoming subcutaneous launch and pipeline expansion. Despite some short-term volatility and analyst-driven EPS misses, the community remains heavily bullish, citing consistent guidance raises and persistent acquisition rumors as primary drivers for long-term value.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is experiencing high volatility as investors weigh the stock's heavy debt load and high-interest financing costs against a massive AI compute backlog. While the company faces skepticism regarding its ability to scale infrastructure amid capital intensity, the community is actively debating its potential as a long-term AI backbone versus the risks of massive institutional selling and leverage unwinding.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca is actively generating headlines following a $445 million expansion of its Texas manufacturing facility to boost production of its potassium-regulating medication and positive Phase III trial results for Imfinzi in gastric cancer treatment. Market sentiment remains focused on the company's robust oncology pipeline and its ongoing integration into the NYSE, as investors weigh its aggressive global growth strategy against broader pharmaceutical sector volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zacks.com featured highlights include Harmony Biosciences, Invesco, General Motors, Hewlett Packard and Quanex Building

Harmony Biosciences leads a screen of undervalued price-to-book stocks, highlighting companies with low valuations and projected long-term earnings growth.

5 Undervalued Price-to-Book Stocks Worth Adding to Your Portfolio

Harmony Biosciences, Invesco, GM, HPE and Quanex made the screen of low price-to-book stocks that also met multiple value metrics.



NX vs. ROAD: Which Stock Is the Better Value Option?

Should Value Investors Buy Quanex Building Products (NX) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Construction Partners (ROAD) Soars 6.7%: Is Further Upside Left in the Stock?

Construction Partners (ROAD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Quanex Building Products Q2 Earnings Call Highlights

Quanex Building Products Q2 Earnings Call Highlights...

Quanex Building Products (NX) Tops Q2 Earnings and Revenue Estimates

Quanex (NX) delivered earnings and revenue surprises of +13.64% and +0.87%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?

Quanex Q2 Profit Falls But Revenue Edges Higher

(RTTNews) - Quanex Building Products Corp. (NX) on Thursday reported lower second-quarter earnings, despite a modest increase in sales...

Analysts Estimate Quanex Building Products (NX) to Report a Decline in Earnings: What to Look Out for

Quanex (NX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Quanex Building Products (NX) Shares Cross Above 200 DMA

In trading on Thursday, shares of Quanex Building Products Corp (Symbol: NX) crossed above their 200 day moving average of $17.28, changing hands as high as $17.59 per share. Quanex Building Products Corp shares are currently trading up about 2.4% on the day. The chart below s...

$NX Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.07 down -84.09% YoY
• Reported revenue of $462.37M up 2.19% YoY
• Quanex expects to recover price versus cost imbalance shortfall during the second half of the year, assuming normal seasonality and subsiding inflation, while prioritizing debt repayment and opportunistic share repurchases.

Quanex Building Products Corp. engages in the manufacturing and distribution of components for original equipment manufacturers in the building products industry. It operates through the following segments: Hardware Solutions, Extruded Solutions, and Custom Solutions. The Hardware Solutions segment manufactures engineered window and door hardware, screens, and other fenestration components. The Extruded Solutions segment manufactures insulating-glass spacers, vinyl and composite profiles, and sealing solutions used in the fabrication of windows, doors, conservatories, roofs, and related building applications. The Custom Solutions segment delivers a diverse range of engineered product solutions which includes wood, metal, and elastomeric materials to residential, commercial, and industrial end markets. The company was founded in 1927 and is headquartered in Houston, TX.

Quanex Building Products Corp

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$19.22
Prev Close	$17.84
Open	$18.01
Dividend Yield	2.25%
50-Day Moving Average	$17.60
Beta	1.40
Avg. Volume	328,230.87
PE Ratio	-3.42

52-Week High	$22.98
52-Week Low	$11.04
Market Capitalization	$819.35M
EPS (Annual)	-$5.43
Price to Book	1.21
Revenue Per Employee	$259,884.17

Feed

News

Sentiment

Earnings

Fundamentals

Info